Analysis of midodrine exposures reveals trends in outcomes reported by poison centers, highlighting potential risks.
Introduction Midodrine is an oral alpha-1 adrenergic agonist used to treat orthostatic hypotension. Its vasoconstrictive properties can lead to hypertension and reflex bradycardia. We characterized midodrine exposures reported to United States poison centers from 2000 to 2023.
No takes yet. Share an insight, caveat, or question.
Kuai et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: